Archer Aviation

Phase A — Understand the business

Company Overview

Archer is a development-stage company "building a platform to deliver advanced aircraft, technologies and services… across commercial and defense sectors". The product is Midnight, a piloted electric vertical-take-off-and-landing (eVTOL) aircraft — four passengers + one pilot, built on a proprietary "12-tilt-6 distributed electric propulsion platform," optimized for ~20-mile, high-frequency urban trips with minimal recharge between flights. The business is not yet a business: FY2025 revenue was $0.3M (hangar sublease from the Hawthorne Airport acquisition), cost of revenue $0.3M. Q1 2026 revenue was $1.6M against a $217.7M net loss. There is no commercial flight revenue.

Three planned lines of business:

1. UAM / air taxi (the core) — own-and-operate networks connecting metros to hubs, plus aircraft sales to airline partners.
2. Defense — a dual-use hybrid-electric VTOL co-developed with Anduril; first third-party tech-adoption deal (Anduril + EDGE Group's "Omen" autonomous air vehicle uses Archer's electric powertrain) announced Nov 2025. Early-stage; optionality, not thesis.
3. Aviation technologies — selling powertrains/components, AI/autonomy and air-traffic tech.

Customers / contract structure. The flagship commercial contract is the United Airlines purchase agreement: up to $1.0B of aircraft + a $500M option — but explicitly conditional on FAA certification and on further negotiation of "material terms" (specs, warranties, delivery, performance guarantees). This is an indicative order, not firm backlog — no take-or-pay, no committed cash. International launch customer is Abu Dhabi Aviation in the UAE. our figures is empty on the shelf — no concentration data compiled; the de-facto picture is a handful of conditional/strategic relationships, not a revenue book.

Supply Chain

Map: upstream component & cell suppliers → Archer (in-house powertrain, flight controls, integration) → manufacturing (Stellantis-built ARC plant) → airline/government operators → passenger. Named stakeholders:

• Strategic / manufacturing partner: Stellantis — built the ARC facility in Covington, Georgia (400,000 sq ft), contributing capital, manufacturing technology and personnel, targeting 650 aircraft/yr by 2030. Chokepoint / red flag: the definitive manufacturing agreement is still only a Memorandum of Understanding (effective Nov 1, 2024 with FCA US LLC); "We have not yet executed the final agreement and there is no assurance that we will… in the near term or at all". The single most important industrial relationship is contractually unfinished.
• Components: Archer says Midnight uses "systems and components from leading aerospace suppliers, many of which are already used on certified aircraft… to reduce certification risk". Specific tier-1 suppliers (motors aside, which are in-house) are not enumerated on the shelf — this lens is thinner than ideal; the robotics commercial layer does not cover eVTOL.
• Single-source dependency — batteries/cells: an eVTOL is a battery-energy-density problem; cell supply and chemistry are an implicit chokepoint, not disclosed by named cell vendor on the shelf.
• Downstream operators: United (US, conditional), Abu Dhabi Aviation (UAE launch). Infrastructure chokepoint: vertiports — Archer is acquiring/redeveloping Hawthorne Airport ($127.1M) as its LA hub.

Names present, but the supply chain is shallow on tier-1 component vendors — flagged.

Competitive Advantages (moats)

The honest read: the moat is a regulatory head-start and a manufacturing partnership, not a durable economic moat — yet.

• First-mover certification position (the real asset): in April–May 2026 Archer became the first eVTOL developer to close FAA Type Certification Phase 3 and received FAA acceptance of 100% of its "Means of Compliance". A Type Certificate, once won, is a genuine regulatory moat (years and ~$1B+ to replicate). But it is not yet won — Archer is in Phase 4 of 4, with the hardest demonstrations ahead.
• Manufacturing scale via Stellantis — auto-industry mass-production expertise applied to aircraft is a credible differentiator vs. hand-built competitors, if the final agreement closes.
• In-house powertrain / flight-control IP — proprietary 12-tilt-6 architecture; the powertrain is now being licensed into defense (Anduril/EDGE Omen), a small validation of the tech moat.
• Bargaining power: weak today. Pre-revenue, Archer needs its customers (United, Abu Dhabi) and its manufacturing partner (Stellantis) more than they need it — milestone-funded relationships that can be "reduced, delayed or terminated". Network effects (vertiport density, route liquidity) are a future moat that does not exist at zero flights.

Verdict on moat: narrow and contingent. The category itself (eVTOL air taxi) is unproven — no one has shown the unit economics work at scale. Archer's edge over the field is execution sequencing, not a defensible economic castle.

Segments

No meaningful segment breakout exists — Archer is a single pre-revenue R&D entity. our figures is empty on the shelf. The "segments" that matter are the spend lines, not revenue:

• R&D: FY2025 $493.9M (+38.1% YoY from $357.7M); Q1 2026 $171.7M (vs $103.7M) — accelerating sharply as the Midnight flight-test/cert program scales.
• G&A: FY2025 $235.4M (+54.9% YoY from $152.0M), of which $128.2M was stock-based comp; Q1 2026 $83.2M.
• Geography: US (certification, Georgia/California manufacturing, LA hub) + UAE (international launch market). UAE is structured to generate the first commercial revenue ahead of full US cert.

Trend: decelerating runway, accelerating burn. Both spend lines are growing 40–55%/yr. The "segment story" is simply: every quarter buys closer to certification at a rising cash cost.

---

Phase B — Measure performance

(Pre-revenue: read as cash-runway-and-milestone analysis, not earnings.)

Latest Result (Q1 2026, reported 2026-05-11)

There is no "beat/miss vs consensus on revenue" for a company with $1.6M of revenue — the print is read on burn, balance sheet, and certification milestones.

• Revenue $1.6M (vs $0 in Q1 2025) — immaterial.
• Total opex $256.2M (R&D $171.7M + G&A $83.2M + COGS $1.3M); loss from operations −$254.6M; net loss −$217.7M (helped by $16.4M interest income + $20.6M other income/warrant remeasurement).
• Net loss per share −$0.28; weighted shares 766.85M (vs 540.4M a year earlier — ~42% more shares YoY).
• Operating cash burn −$149.1M for the quarter.
• Balance sheet: cash + equivalents $951.1M, short-term investments $824.8M → total liquidity $1,775.9M at 3/31/26, down from $1,964.7M at 12/31/25 (−$188.8M in one quarter). Total debt only ~$80M (Synovus + Banc of California). Stockholders' equity $2,079.4M; accumulated deficit −$2,521.5M.
• Guidance / tone: management guided Q2 2026 adjusted-EBITDA loss of $170M–$200M — i.e. burn stays heavy or rises. The 10-QForm 10-QThe quarterly version of the annual report. Lighter, and not audited. reaffirms liquidity is "sufficient… for at least the next 12 months" — a fund-for-12-months statement, not a fund-to-profitability one.
• What drove the quarter: not commercial traction — certification progress. The market reaction in 2026 has tracked cert headlines (Phase 3 close, 100% Means of Compliance, UAE RTC) far more than the income statement.
• Unusual vs own history: R&D up ~66% YoY in a single quarter; cash drawdown accelerating. Normal for a pre-cert eVTOL — but the clock is the story.

Earnings Calls (sentiment trend)

transcripts/ is empty on the shelf (no transcripts ingested) — sentiment read is, lower confidence.

• Consistent management framing: "record FAA certification progress," "initial US operations expected in 2026," "first to [X cert milestone]" — Archer's investor narrative is milestone-superlative-led.
• Tone shift over 2025→2026: language has migrated from "advanced aviation" (FY2025 10-KForm 10-KA company’s audited annual report to the US regulator. The most complete thing it publishes.) to "aerospace and defense" (Q1 2026 10-Q overview) — a deliberate repositioning that leans into the Anduril defense optionality and the broader AI/autonomy story. This is partly narrative management as the pure air-taxi timeline slips.
• Recurring emphasis: "first," certification phases, UAE launch, Stellantis manufacturing. Things de-emphasized: firm order economics, dates for piloted transition flight, unit economics — the hard commercial proof points.
• Net: promotional, confident, milestone-anchored. Treat the superlatives as marketing; weight the SEC-disclosed contingencies higher.

Comps

Pre-revenue eVTOL — earnings/EBIT multiples are meaningless; the relevant comp is the direct rival (Joby) on cash, certification stage, and book value. Multiples are or n/a.

Read: Joby is valued ~2.5–3x Archer, holds more cash (~$2.5B vs $1.78B), is a full FAA stage ahead (Stage 5 vs Phase 4), and already guides to real 9-figure revenue (largely via Blade acquisition + Dubai). Archer trades at a lower P/B (1.75x vs 4.44x) with less debt (debt/cap 3.65% vs 26.37%) — the cheaper, more leveraged-to-catalyst, more behind name. The comp does not say Archer is mispriced cheap; it says Archer is the laggard with a bigger discount and bigger catch-up/binary risk.

Stock-Price Catalysts (what moves ACHR >5%)

The pattern is unambiguous: ACHR is a certification/headline stock, not a fundamentals stock. Moves over the last ~18 months:

• Up: FAA cert milestones (Phase 3 close + 100% Means of Compliance → +13% intraday, Apr/May 2026); UAE RTC acceptance + Abu Dhabi Aviation partner (May 2026); Anduril/EDGE defense powertrain deal + FAA test progress (+9.6%, late 2025/2026); eIPP application wins (TX/FL/NY); large capital raises (paradoxically supportive — removes funding risk).
• Down: the 52-week range $14.62 → $4.61 (now ~$4.76) tells the dominant story — a ~67% drawdown from the peak as the air-taxi timeline pushed right and dilutionDilutionIssuing new shares, so each existing share owns a smaller slice of the same company. mounted; Q2 EBITDA-loss guidance; rising short interestShort interestHow many shares have been borrowed and sold by people betting the price falls.; broad de-risking of speculative/2026-revenue names.
• What the market actually reacts to: binary regulatory/technical events (cert phase, transition flight, RTC) and funding events. It does not react to the P&L. Therefore the next identifiable mover is the piloted transition flight + Phase 4 TIA progress in 2H 2026.

---

Phase C — Judge people & books

Management

• CEO & Chairman: Adam Goldstein. Co-founded Archer in 2018 with Brett Adcock; sole CEO since April 2022 when Adcock stepped down (Adcock left to found Figure/robotics). Prior track record: co-founded Vettery, a recruiting marketplace, sold to Adecco for ~$110M in 2018. University of Florida engineering alum.
• Archetype: founder-operator / fundraiser-salesman, NOT an aerospace engineer. Goldstein's demonstrated skill is capital formation and partnerships — he has repeatedly funded a cash-incinerating company through equity markets (see Lens 5/10), landed Stellantis, United, Boeing-veteran hires, the UAE, and Anduril. That is exactly the skill a pre-revenue capital-intensive certification project needs at this stage. The open question is whether the same skill set delivers operational/manufacturing execution post-cert.
• Skin in the game / comp: large founder equity stake; Founder Grants are market-/performance-condition RSUs tied to stock-price and milestone hurdles (Monte Carlo–valued) — incentives are equity-upside-aligned but also dilutive and promotional-leaning (stock-price triggers reward narrative). our figures not on shelf — insider buy/sell pattern not verified here.
• Capital allocation: the defining act is serial dilution to fund R&D — raised ~$1.8B of equity in 2025 alone (registered directs Feb/Jun/Nov 2025: $301.8M, $850M, $650M gross). Also paid $126.8M of vendor obligations in stock in 2025, and acquired Hawthorne Airport for $127.1M. This is "raise while you can, spend to certify" — rational for the stage, brutal for per-share value.
• Red flags (management): promotional, superlative-heavy communications; the "aerospace and defense" repositioning; the still-unsigned Stellantis definitive agreement; the 10-K's own admission that internal-control / disclosure-control weaknesses "have been identified in the past and may be identified in the future" — though the FY2025 audit (PwC) issued a clean opinion on both financials and ICFR.

Forensic Red Flags

No fraud/accounting-quality alarm — but the structural cash-and-dilution profile is the whole risk. Auditor PwC, auditor since 2020, unqualified opinion on FY2025 statements and internal controls.

Income statement: clean — there's almost no revenue to manipulate. Watch stock-based comp: $223.5M in FY2025 (34% of net loss, up from $108.8M in 2024) — this flatters operating-cash burn vs. net loss and is genuinely dilutive.

Balance sheet / cash flow:

• Cash vs earnings divergence is benign — net loss −$618.2M but operating burn only −$432.9M FY2025, the gap mostly non-cash SBC ($223.5M) and warrant-fair-value gains (−$59.5M). The warrant-remeasurement (Stellantis warrants) injects non-operating volatility into "other income" — Q1'26 had +$20.6M, FY2025 +$58.6M — inflating reported results in a way unrelated to the business.
• Goodwill/intangibles: small ($2.4M goodwill, $81.6M intangibles at 3/31/26) from Hawthorne — low impairment risk. The Critical Audit Matter was the $44.8M fair value of the FBO purchase option in the Hawthorne deal (income-approach, subjective discount-rate/revenue assumptions) — a contained, well-flagged estimate.
• The real "red flag" is not forensic, it's existential: ~$1.8B liquidity against ~$700–800M/yr and rising cash burn = roughly 2–2.5 years of runway before commercial revenue scales, against a certification timeline that keeps slipping right. Continued large equity raises are essentially guaranteed → persistent, structural per-share dilution (157M shares 2021 → 757.9M at 3/31/26, ~4.8x in five years).

Regulatory findings (required sub-section).

• SEC Litigation Releases / AAERs: None. regulatory/regulatory-findings.md reports 0 LR and 0 AAER naming Archer Aviation, searched 2021-06-30 → 2026-06-30 via EDGAR EFTS.
• 10-K Item 3 (Legal Proceedings): Archer discloses no material pending litigation — Item 3 incorporates Note 7 (Commitments & Contingencies) by reference and states management believes ordinary-course claims "individually or in aggregate, will not have a material adverse impact". (Historical note for context, not on-shelf: Archer's 2021 trade-secret dispute with Wisk Aero was settled in 2023 — no longer active.)
• Non-SEC enforcement (FTC/DOJ/FAA/etc.): no material enforcement actions surfaced; the FAA relationship is regulatory-process (certification), not enforcement.
• Conclusion: No material regulatory or legal findings — verified via SEC EDGAR EFTS (LR, AAER), web search, and 10-K Item 3 as of 2026-06-30. The risk here is dilution and timeline, not malfeasance.

---

Phase D — Project & stress-test

Forward Projection

An EPS projection is not the right tool — Archer is pre-revenue and will post net losses through the forecast window. The honest projection is cash runway vs. the value-inflection catalyst (the +clinical/+private-style framing the SKILL prescribes for pre-revenue names), built bottom-up from the actuals. (No our model forecast logged — watchlist rule; and a binary cert/flight event, not an EPS line, is the scoreable variable.)

Runway math (the core projection):

• Liquidity 3/31/26: $1,775.9M.
• Q1'26 operating burn $149.1M; management guides Q2 adj-EBITDA loss $170–200M. Call cash burn ~$160–190M/quarter and rising.
• Add capexCapital expenditureMoney spent on long-lived things — buildings, machines, servers — rather than on running costs. (manufacturing build-out, vertiports) — FY2025 PP&E purchases were $78.8M, likely rising.
• Implied total cash outflow ~$700–850M/yr → roughly 2 to 2.5 years of runway on current cash, before any further raise. Management's own "12 months" assurance is deliberately conservative and assumes more financing.

Three-year P&L sketch (net loss, $M) — every line off the actuals:

• Bull path: TC by ~2027, UAE + US ops compound, Stellantis hits volume → revenue inflects toward Joby's trajectory; the option pays off multiples.
• Bear path: transition-flight/TC slips into 2027–28, another $1B+ dilutive raise at a depressed price, revenue stays sub-$50M → shares double again from 758M and the stock re-rates down.
• Scoreable forecast (logged conceptually, not written): the right binary is "Archer completes a piloted transition flight under FAA observation by 2026-12-31" — base probability ~55–65%; uncrewed transition done; piloted transition is the explicit 2H'26 plan but historically these slip]. This single event, more than any EPS number, drives the stock.

Bull vs Bear

Bull case. Archer is the best-funded, fastest-certifying Western air-taxi pure-play after Joby, holding a first-mover regulatory position (first to close FAA Phase 3, 100% Means of Compliance) and a uniquely credible manufacturing edge (Stellantis, 650 a/c/yr target). It has engineered a revenue-before-US-cert path via the UAE (GCAA Restricted Type Certificate, Abu Dhabi Aviation operator) that de-risks the "can it ever fly commercially" question ahead of peers' home markets. The Anduril/EDGE defense powertrain deal opens a second, higher-margin, dual-use TAM with a tier-1 defense partner — pure optionality the market currently values near zero. If urban air mobility becomes a real category this decade, Archer is one of two or three names that own the runway. At ~$3.6B with $1.78B of cash, ~half the EVEnterprise valueWhat it would cost to buy the whole company: its market value plus its debt, minus the cash you would get with it. Often very different from market cap. is the cash pile — a cheap call option on a trillion-dollar-TAM narrative.

Bear case (permanent-impairment risks).

1. The category may not have viable unit economics at all — no eVTOL operator has demonstrated profitable air-taxi operations; vertiport capex, pilot cost, battery cycle life, and load factors could make the network math never close. This impairs the whole industry, Archer included.
2. Dilution as a structural feature, not a bug — funding ~$750M/yr of burn from equity markets means the share count keeps compounding (4.8x in 5 yrs). Even a successful certification can be a bad investment if you're diluted 30–50% more before revenue scales. The bull case can be right about the company and wrong about the stock.
3. Joby is ahead and better funded — a full FAA stage ahead, ~$2.5B cash, real revenue guide. If air-mobility is winner-take-most, being the laggard is a permanent strategic disadvantage.

Pre-mortem (it's Dec 2027 and the thesis broke): the piloted transition flight slipped twice; FAA TC pushed to 2028; Archer did a $1.2B raise at ~$3.50 in late 2026 (share count > 900M); UAE ops stayed sub-scale and money-losing; Joby launched US commercial first and took the airline/vertiport partnerships; ACHR re-rated to ~$2.50 as a "story that needed one more year, again."

Are multiples too high? There is no earnings multiple. On P/B (1.75x) Archer is cheaper than Joby — but book is mostly cash that is being burned. The valuation is entirely a probability-weighted call on certification + commercialization, and the market has already written down the timeline (−67% from peak). Not obviously expensive; not obviously cheap; binary.

Contrarian view (what the market refuses to see): the consensus is fighting over "Archer vs Joby air-taxi." The under-priced variant is that Archer's powertrain/battery becomes a defense and industrial component business (Anduril/EDGE is the tell) — a supplier model that monetizes the IP without the brutal economics of owning an airline. If management leans into "we are an electric-aerospace-propulsion company that also flies taxis," the defense optionality is worth more than the air-taxi DCF the bears discount to zero.

Devil's Advocate (short-seller)

Dismantling the bull case — and the ~18.6% short interest (123.3M shares) says the market already is.

• How the money-making breaks structurally: Archer doesn't make money — it makes milestones. The entire equity value rests on events (TC, transition flight, commercial launch) that have repeatedly moved right. The bull "first to Phase 3" headline obscures that it's still Phase 4 of 4 with the hardest, longest demonstrations (TIA, for-credit flight test) ahead, and a piloted transition flight — table stakes — has not yet been publicly flown. Joby is past this.
• Revenue concentration: there is no revenue to concentrate. The "order book" (United $1.0B) is explicitly conditional and non-binding — it can evaporate with a timeline slip or a spec disagreement. UAE is the only near-term revenue and it depends on a foreign regulator and a single operating partner.
• Why the moat is weaker than bulls think: the "moat" is a TC Archer doesn't have yet, and a manufacturing deal that is still an MOU. Both Joby (ahead) and well-capitalized entrants (Embraer/Eve, Chinese players like EHang already operating) can replicate. Distributed-electric-propulsion IP is not unique.
• Most dangerous competitor bulls underestimate: Joby — more cash, a stage ahead, real revenue, Toyota manufacturing partner and Dubai head-start. Secondarily, Chinese eVTOL (EHang) which is already flying commercially under CAAC — proving the category can launch without Archer.
• Worst capital-allocation reality: management's core competency is issuing stock. ~$1.8B raised in 2025; vendors paid in shares; a 4.8x share-count explosion. Founder Grants reward stock price, incentivizing narrative.
• Assumptions that must hold for today's ~$3.6B price: (1) FAA TC by ~2027; (2) the category produces positive unit economics; (3) Archer remains a top-2 winner; (4) dilution stays "manageable." Break any one and the option is worth far less.
• −20–30% growth disappointment: if the 2H'26 transition flight / Phase 4 progress disappoints, expect another leg down toward the 52-wk low (~$4.61) or below, plus a forced dilutive raise that compounds the damage.
• Single scenario that permanently impairs the business: a fatal or serious test-flight accident, or a multi-year FAA TC delay that forces a raise the market won't fund on reasonable terms — a death-spiral for a pre-revenue cash-burner. Plausibility: low-but-not-trivial (test programs carry real safety risk; timelines have already slipped).

Management Questions (ordered by information value)

1. What specifically gates the piloted transition flight, and what is your honest confidence it happens in 2026 — given it's slipped before? (The single highest-value answer; the stock's next catalyst.)
2. Walk me through the unit economics of one Midnight on one route at scale — revenue/flight, pilot + energy + maintenance cost, daily utilization, and the load factor where a vertiport network turns cash-positive. (Tests whether the category economics close at all.)
3. When does the Stellantis manufacturing relationship convert from MOU to a definitive, binding agreement — and what is the consequence if it doesn't?
4. How much additional capital do you expect to raise before sustained commercial revenue, and how should shareholders think about the dilution path from 758M shares?
5. Of the $1.0B United order, how much converts to firm, cash-committed deliveries the day you receive a Type Certificate — and what material terms remain unagreed?
6. What is the realistic FAA Type Certificate date, and what are the top two technical risks in the remaining Phase 4 for-credit testing?
7. What does UAE commercial operation actually contribute in 2026–2027 — revenue, margin, and is it profitable or a marketing/credibility exercise?
8. Is Archer better understood as an air-taxi operator or an electric-aerospace propulsion supplier? How big could the Anduril/EDGE-type component business be, and would you prioritize it?
9. You're a full FAA stage behind Joby with less cash — what is your credible path to not being the structural laggard in a winner-take-most market?
10. What is the long-run gross margin of (a) selling aircraft vs (b) operating the network, and which is the real business?
11. How dependent is Midnight's range/payload/economics on battery energy-density improvement, and who is your cell supplier / what's your second source?
12. What share-price- or milestone-linked comp could vest in the next 24 months, and how dilutive is it?
13. What vertiport/charging infrastructure must exist for an LA network, who pays for it, and what's the capex you're committing vs. partners?
14. Given internal-control weaknesses "identified in the past," what specifically has been remediated?
15. At what cash level or timeline slip would you change strategy — pause manufacturing build-out, narrow to UAE-only, or pivot toward the component/defense model?

---